Juvabis is Drug Discovery in Switzerland that focus on clinical-stage bio business. Founded in 2015. They cover business area such as developer, next-generation therapeutic, bacterial infection, next-generation antibacterial therapeutic, mechanism, bacterial drug-resistance, superior tolerability, increase target selectivity, rational design, doctor, a cure, highly drug resistant infection.
2015
( 11 years old in 2026 )
Clinical-stage Bio
-
Schützengasse 1
8001 Zürich
Switzerland
Private
developernext-generation therapeuticbacterial infectionnext-generation antibacterial therapeuticmechanismbacterial drug-resistancesuperior tolerabilityincrease target selectivityrational designdoctora curehighly drug resistant infection
* We use standard office opening hours in near Juvabis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Juvabis is Drug Discovery business from Switzerland that founded in 2015 (11 years old in 2026), Juvabis business is focusing on Clinical-stage Bio.
Juvabis headquarter office and corporate office address is located in Schützengasse 1 8001 Zürich Switzerland.
Juvabis was founded in Switzerland.
In 2026, Juvabis is currently focus on clinical-stage bio sector.
Above is snippet of Google Trends for "clinical-stage bio" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Juvabis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
